Sutirtha Chatterjee (Information Systems) has been honored with the Outstanding Reviewer Award by the European Journal of Information Systems, a prestigious journal on the Lee SARS list. This recognition highlights Chatterjee's exceptional contributions to the peer review process, ensuring the integrity and quality of academic research.

Hamidreza Nikkhah (Management, Entrepreneurship, and Technology) recently published the article, "Strategizing Responses to Data Breaches: A Multi-Method Study of Organizational Responsibility and Effective Communication with Stakeholders," in the Journal of Management Information Systems. This significant achievement focuses on response…

Professor David Orentlicher (Law) presented at the New Frontiers in Comparative Law: A Works-in-Progress Showcase at the 2025 Association of American Law Schools (AALS) Annual Meeting. 

Professor Lydia Nussbaum (Law) spoke on a panel on The Courage to Change How We Educate the Next Generation: Dispute Resolution and Professional Identity Formation Across the Curriculum at the 2025 Association of American Law Schools (AALS) Annual Meeting. 

Professors Benjamin Edwards (Law) was a commentator for the Works-in-Progress in Securities Regulation session at the 2025 Association of American Law Schools (AALS) Annual Meeting. 

Professors Benjamin Edwards (Law) spoke on Internet and Computer Law - Financial Regulation in Cyberspace at the 2025 Association of American Law Schools (AALS) Annual Meeting. 

Professors Benjamin Edwards and Joe Regalia (both Law) sat on a panel about Professional Responsibility in An Age of Technological Change at the 2025 Association of American Law Schools (AALS) Annual Meeting. Professor Edwards was the moderator and Professor Regalia was a speaker on the panel. 

Professor Frank Rudy Cooper (Law) was a discussant for "Tightrope: Teaching Criminal Law to First-Year Students in a Polarized Moment" at the 2025 Association of American Law Schools (AALS) Annual Meeting. 

Dr. Jeffrey L. Cummings (Brain Health) is the lead author of recently published article titled, "evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease." This article is a description of two large…